from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1156/-

LFCtreatmentdescriptionclass of inhibitor

-0.409

Amikacinug/mL Amikacintranslation

0.236

Cap5-10ug/mL Capreomycintranslation

0.987

Rox10-50 ug/mL Roxithromycintranslation

0.707

SM2-5 ug/mL Streptomycintranslation

0.885

Tet5-10 ug/mL Tetracyclinetranslation

-1.565

Rif0.2-5ug/mL Rifampicintranscription

-1.625

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.887

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.527

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.475

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.395

Clofazimine10-13 ug/mL Clofaziminerespiration

0.160

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.024

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.489

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.650

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.055

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.290

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.939

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.249

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.441

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.229

KCN5-20 ug/mL Potassium cyaniderespiration

1.268

NaN30.2-2 mM Sodium aziderespiration

0.485

Nigericin50 uM Nigericinrespiration

-0.453

TRC10-150 ug/mL Triclosanrespiration

-1.335

TRZ10-25 ug/mL Thioridazinerespiration

-0.427

Valinomycin0.5-10 uM Valinomycinrespiration

0.025

ZnSO42 mM ZnSO4respiration

0.410

menadione6-10 ug/mL Menadionerespiration

-0.599

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.228

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.175

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.165

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.732

NRP_1Non-replicating persistence stage 1dosRassociated

-0.189

Amp0.2mg/mL AmpicillincellWall

-0.224

Cephalexin20-100 ug/mL CephalexincellWall

-0.342

Cerulenin0.32-5 ug/mL CerulenincellWall

0.080

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.434

EMB10-20 ug/mL EthambutolcellWall

0.088

Eta12-40 ug/mL EthionamidecellWall

-0.136

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.093

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.509

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.285

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.877

BZA0.12 mg/mL BenzamidearomaticAmides

1.430

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

2.001

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.990

H2O24 mM hydrogen peroxideDNAdamaging

-0.261

Levo10 ug/mL LevofloxacinDNAdamaging

0.092

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.473

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.233

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.132

UVUV-irradiationDNAdamaging

-0.126

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.348

Antimycin12.5-50 ug/mL Antimycin A?

-0.322

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.309

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.240

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.548

PA8240.2-2 ug/mL PA-824?

0.849

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.192

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.994

Verapamil50 uM Verapamil?

-0.396

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.033

methoxatin10-20 ug/mL Methoxatin?